Publicacións en colaboración con investigadores/as de Sociedad Española de Reumatología (116)

2017

  1. Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

    Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942

2016

  1. Centre characteristics determine ambulatory care and referrals in patients with spondyloarthritis

    Rheumatology International, Vol. 36, Núm. 11, pp. 1515-1523

  2. Centre-related variability in hospital admissions of patients with spondyloarthritis

    Rheumatology International, Vol. 36, Núm. 9, pp. 1301-1308

  3. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

  4. Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580

2015

  1. Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)

    Rheumatology International

  2. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis

    Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137

2014

  1. Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 353-360

  2. Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: Data from the Spanish registry BIOBADASER 2.0

    Rheumatology International, Vol. 34, Núm. 7, pp. 953-961

  3. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 7, pp. 1350-1355

  4. Índices compuestos para evaluar la actividad de la enfermedad y el daño estructural en pacientes con lupus eritematoso: Revisión sistemática de la literatura

    Reumatologia Clinica

2013

  1. Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: Study using the spanish registry of adverse events of biological therapies in rheumatic diseases

    Arthritis Care and Research, Vol. 65, Núm. 12, pp. 2024-2031

  2. Denosumab for the treatment of osteoporosis: A systematic literature review

    Reumatologia Clinica, Vol. 9, Núm. 1, pp. 42-52

  3. Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER

    Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225

  4. Factores motivadores y barreras para implantar una vía clínica de atención precoz de espondiloartritis: Estudio cualitativo con médicos de atención primaria

    Reumatologia Clinica, Vol. 9, Núm. 2, pp. 85-89

  5. Fe de errores de «Mortalidad en las enfermedades reumáticas: Un metaanálisis»

    Reumatologia Clinica

  6. Quality-of-care standards for early arthritis clinics

    Rheumatology International, Vol. 33, Núm. 10, pp. 2459-2472

  7. Reducing the need for central dual-energy X-ray absorptiometry in postmenopausal women: Efficacy of a clinical algorithm including peripheral densitometry

    Calcified Tissue International, Vol. 93, Núm. 1, pp. 62-68

  8. Tackling missing radiographic progression data: Multiple imputation technique compared with inverse probability weights and complete case analysis

    Rheumatology (United Kingdom), Vol. 52, Núm. 2, pp. 331-336

2012

  1. A meta-analysis of mortality in rheumatic diseases

    Reumatologia Clinica, Vol. 8, Núm. 6, pp. 334-341